# PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN

> **NCT00274599** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 812 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Ramipril

## Key facts

- **NCT ID:** NCT00274599
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10-09
- **Primary completion:** 2003-11-30
- **Final completion:** —
- **Target enrollment:** 812 (ACTUAL)
- **Last updated:** 2023-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274599, "PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00274599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*